Lu Wang
ORCID: 0000-0003-2617-655XAlso affiliated with Ministry of Education, Affiliated Hospital of Guizhou Medical University, Ningxia Medical University, Henan Provincial People's Hospital, Ningxia Medical University General Hospital, Gilead Sciences (United States), Jiangsu Hengrui Medicine (China), Second Affiliated Hospital of Zhejiang University, Ocean University of China
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial”.
David Vicente, Takayasu Kurata, David Planchard, Luis Paz‐Ares, Johan Vansteenkiste +18 more
Jiefeng Gan, Jiyun Sun, Zhen Chen, Hualong Fu, Jian Rong +9 more
Katsushi Kumata, Zhen Chen, Yiding Zhang, Jiahui Chen, Akiko Hatori +18 more
Chunyu Zhao, Xiaotian Xia, Guocong Li, Ahmed Haider, Huiyi Wei +9 more
Jiahui Chen, Jimmy S. Patel, Wenqing Ran, Yinlong Li, Richard Van +19 more